PE20070167A1 - COMPUESTOS 5H-BENZO[4,5]CICLOHEPTA[1,2-b]PIRIDINA COMO INHIBIDORES DE TIROSINA QUINASA - Google Patents
COMPUESTOS 5H-BENZO[4,5]CICLOHEPTA[1,2-b]PIRIDINA COMO INHIBIDORES DE TIROSINA QUINASAInfo
- Publication number
- PE20070167A1 PE20070167A1 PE2006000702A PE2006000702A PE20070167A1 PE 20070167 A1 PE20070167 A1 PE 20070167A1 PE 2006000702 A PE2006000702 A PE 2006000702A PE 2006000702 A PE2006000702 A PE 2006000702A PE 20070167 A1 PE20070167 A1 PE 20070167A1
- Authority
- PE
- Peru
- Prior art keywords
- cyclohepta
- benzo
- compounds
- alkyl
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS 5H-BENZO[4,5]CICLOHEPTA[1,2-b]PIRIDINA, DE FORMULA (I) DONDE R1 ES ARILO, HETEROARILO AMBOS OPCIONALMENTE SUSTITUIDOS CON 1 A 5 SUSTITUYENTES R8; O NR10R11; DONDE R10 Y R11 SON INDEPENDIENTEMENTE H, (C=O)ObALQUILO(C1-C10), (C=O)ObCICLOALQUILO(C3-C8), ENTRE OTROS; R5 ES H, ALQUILO(C1-C6), ALQUENILO(C2-C6), -O-ALQUILO(C1-C6), -O-C(=O)ALQUILO(C1-C6), ENTRE OTROS; b ES 0 O 1. SON COMPUESTOS PREFERIDOS: 3-FENIL-7-VINIL-5H-BENZOL[4,5]CICLOHEPTA[1,2-b]PIRIDIN-5-ONA, 7-ETIL-3-FENIL-5H-BENZO[4,5]CICLOHEPTA[1,2-b]PIRIDIN-5-ONA, 7-[(2,4-DIMETOXIBENCIL)AMINO]-3-FENIL-5H-BENZO[4,5]CICLOHEPTA[1,2-b]PIRIDIN-5-ONA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. LOS COMPUESTOS SON INHIBIDORES DE LA TIROSINA QUINASA DEL RECEPTOR MET Y SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES PROLIFERATIVAS CELULARES TAL COMO CANCER, HIPERPLASIAS, TRASTORNOS INMUNES E INFLAMACION
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69322905P | 2005-06-23 | 2005-06-23 | |
US72906105P | 2005-10-21 | 2005-10-21 | |
US78947306P | 2006-04-05 | 2006-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070167A1 true PE20070167A1 (es) | 2007-04-16 |
Family
ID=37595817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000702A PE20070167A1 (es) | 2005-06-23 | 2006-06-21 | COMPUESTOS 5H-BENZO[4,5]CICLOHEPTA[1,2-b]PIRIDINA COMO INHIBIDORES DE TIROSINA QUINASA |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1896422B1 (es) |
KR (1) | KR20080018907A (es) |
AR (1) | AR057377A1 (es) |
AT (1) | ATE520664T1 (es) |
BR (1) | BRPI0612518A2 (es) |
CR (1) | CR9579A (es) |
CY (1) | CY1112038T1 (es) |
DO (1) | DOP2006000143A (es) |
EC (1) | ECSP078017A (es) |
IL (1) | IL187895A0 (es) |
MA (1) | MA29643B1 (es) |
MX (1) | MX2007016533A (es) |
NI (1) | NI200700318A (es) |
NO (1) | NO20080417L (es) |
NZ (1) | NZ563711A (es) |
PE (1) | PE20070167A1 (es) |
PL (1) | PL1896422T3 (es) |
PT (1) | PT1896422E (es) |
SI (1) | SI1896422T1 (es) |
TW (1) | TW200738638A (es) |
WO (1) | WO2007002258A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200813021A (en) | 2006-07-10 | 2008-03-16 | Merck & Co Inc | Tyrosine kinase inhibitors |
US7893081B2 (en) * | 2007-12-20 | 2011-02-22 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
EP2482803B1 (en) | 2009-09-30 | 2021-12-22 | Merck Sharp & Dohme (UK) Limited | Formulations for c-met kinase inhibitors |
US8674105B2 (en) | 2009-09-30 | 2014-03-18 | Merck Sharp & Dohme Limited | Crystalline hydrochloride salts of c-Met kinase inhibitors |
JP2013532627A (ja) | 2010-07-01 | 2013-08-19 | 武田薬品工業株式会社 | cMET阻害剤とHGFおよび/またはcMETに対する抗体との組み合わせ |
US10398774B2 (en) | 2014-12-09 | 2019-09-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Human monoclonal antibodies against AXL |
WO2016135041A1 (en) | 2015-02-26 | 2016-09-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fusion proteins and antibodies comprising thereof for promoting apoptosis |
CN114364798A (zh) | 2019-03-21 | 2022-04-15 | 欧恩科斯欧公司 | 用于治疗癌症的Dbait分子与激酶抑制剂的组合 |
AU2020378630A1 (en) | 2019-11-08 | 2022-05-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7211597B2 (en) * | 2001-09-19 | 2007-05-01 | Suzanne Metz | Substituted pyrazolyl compounds for the treatment of inflammation |
WO2003084931A1 (en) * | 2002-04-02 | 2003-10-16 | Merck & Co., Inc. | 5h-benzo[4,5]cyclohepta[1,2-b]pyridine nmda/nr2b antagonists |
-
2006
- 2006-06-14 TW TW095121232A patent/TW200738638A/zh unknown
- 2006-06-16 AR ARP060102571A patent/AR057377A1/es not_active Application Discontinuation
- 2006-06-21 PE PE2006000702A patent/PE20070167A1/es not_active Application Discontinuation
- 2006-06-22 KR KR1020077030202A patent/KR20080018907A/ko not_active Application Discontinuation
- 2006-06-22 EP EP06785319A patent/EP1896422B1/en active Active
- 2006-06-22 WO PCT/US2006/024256 patent/WO2007002258A2/en active Application Filing
- 2006-06-22 NZ NZ563711A patent/NZ563711A/en not_active IP Right Cessation
- 2006-06-22 AT AT06785319T patent/ATE520664T1/de active
- 2006-06-22 BR BRPI0612518-2A patent/BRPI0612518A2/pt not_active IP Right Cessation
- 2006-06-22 PT PT06785319T patent/PT1896422E/pt unknown
- 2006-06-22 MX MX2007016533A patent/MX2007016533A/es unknown
- 2006-06-22 SI SI200631136T patent/SI1896422T1/sl unknown
- 2006-06-22 PL PL06785319T patent/PL1896422T3/pl unknown
- 2006-06-23 DO DO2006000143A patent/DOP2006000143A/es unknown
-
2007
- 2007-12-04 IL IL187895A patent/IL187895A0/en unknown
- 2007-12-04 NI NI200700318A patent/NI200700318A/es unknown
- 2007-12-07 CR CR9579A patent/CR9579A/es not_active Application Discontinuation
- 2007-12-14 EC EC2007008017A patent/ECSP078017A/es unknown
-
2008
- 2008-01-22 NO NO20080417A patent/NO20080417L/no not_active Application Discontinuation
- 2008-01-23 MA MA30591A patent/MA29643B1/fr unknown
-
2011
- 2011-11-16 CY CY20111101099T patent/CY1112038T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1896422B1 (en) | 2011-08-17 |
NZ563711A (en) | 2010-12-24 |
CY1112038T1 (el) | 2015-11-04 |
SI1896422T1 (sl) | 2011-11-30 |
MX2007016533A (es) | 2008-03-06 |
EP1896422A2 (en) | 2008-03-12 |
KR20080018907A (ko) | 2008-02-28 |
PT1896422E (pt) | 2011-11-08 |
ECSP078017A (es) | 2008-01-23 |
BRPI0612518A2 (pt) | 2010-11-23 |
CR9579A (es) | 2008-03-06 |
MA29643B1 (fr) | 2008-07-01 |
NI200700318A (es) | 2008-05-23 |
PL1896422T3 (pl) | 2012-01-31 |
IL187895A0 (en) | 2008-03-20 |
AR057377A1 (es) | 2007-11-28 |
WO2007002258A3 (en) | 2007-06-07 |
NO20080417L (no) | 2008-03-18 |
ATE520664T1 (de) | 2011-09-15 |
DOP2006000143A (es) | 2007-02-28 |
TW200738638A (en) | 2007-10-16 |
WO2007002258A2 (en) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20070167A1 (es) | COMPUESTOS 5H-BENZO[4,5]CICLOHEPTA[1,2-b]PIRIDINA COMO INHIBIDORES DE TIROSINA QUINASA | |
PE20191613A1 (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret | |
PE20220931A1 (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina | |
NZ766835A (en) | Pharmaceutical compounds | |
PE20160875A1 (es) | Compuestos de biaril-amida como inhibidores de cinasa | |
PE20170666A1 (es) | 2-(morfolin-4-il)-1,7-naftiridinas | |
PE20181093A1 (es) | Compuestos heterociclicos y usos de los mismos | |
EA202090659A1 (ru) | СОСТАВЫ, СОДЕРЖАЩИЕ 6-(2-ГИДРОКСИ-2-МЕТИЛПРОПОКСИ)-4-(6-(6-((6-МЕТОКСИПИРИДИН-3-ИЛ)МЕТИЛ)-3,6-ДИАЗАБИЦИКЛО[3.1.1]ГЕПТАН-3-ИЛ)ПИРИДИН-3-ИЛ)ПИРАЗОЛО[1,5-a]ПИРИДИН-3-КАРБОНИТРИЛ | |
PE20181491A1 (es) | Nuevos derivados biciclicos, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
EA200601350A1 (ru) | Азотсодержащие гетероциклические производные и их фармацевтические применения | |
PE20170247A1 (es) | Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1 | |
CL2012001699A1 (es) | Compuestos derivados de n-(1h-indazol-4-il)imidazo[1,2-a]piridin-3-carboxamida sustituidos, inhibidores de cfms; proceso de preparacion; composicion farmaceutica que los comprende; uso del compuesto para el tratamiento de enfermedades relacionadas con huesos, cancer, trastornos autoinmunes, enfermedades inflamatorias, entre otras. | |
EA200700099A1 (ru) | Производные пиридина | |
PE20170003A1 (es) | Compuestos heterociclicos y usos de los mismos | |
ECSP056194A (es) | Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa | |
PA8593001A1 (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
EA200870373A1 (ru) | Пиридил- и пиримидинилзамещённые производные пиррола, тиофена и фурана в качестве ингибиторов киназ | |
AR047531A1 (es) | Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa | |
PE20010211A1 (es) | Compuestos de tiazol y composiciones farmaceuticas para inhibir las quinasas de proteina | |
EA201000615A1 (ru) | Производные имидазо[1,2-а]пиридина, применимые в качестве ингибиторов апк (активиноподобной киназы) | |
CO5700778A2 (es) | Administracion combinada de una indolinona con un agente quimioterapeutico para trastornos de proliferacion celular | |
PE20141598A1 (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
PE20212303A1 (es) | Inhibidores aza-heterobiciclicos de mat2a y metodos de uso en el tratamiento de cancer | |
DE602005016261D1 (de) | Substituierte arylaminderivate und verwendungsverfahren | |
UY29414A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |